PARAQUAT-INDUCED LUNG INJURY - PREVENTION BY VASOACTIVE-INTESTINAL-PEPTIDE AND RELATED PEPTIDE HELODERMIN

被引:22
|
作者
PAKBAZ, H [1 ]
FODA, HD [1 ]
BERISHA, HI [1 ]
TROTZ, M [1 ]
SAID, SI [1 ]
机构
[1] VET AFFAIRS MED CTR, NORTHPORT, NY 11768 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1993年 / 265卷 / 04期
关键词
OXIDANT LUNG INJURY; ANTIOXIDANTS; NEUROPEPTIDES;
D O I
10.1152/ajplung.1993.265.4.L369
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We earlier showed that the neuropeptide vasoactive intestinal peptide (VIP) reduces or prevents acute injury produced in rat lungs by xanthine and xanthine oxidase. We have now examined whether VIP can protect against lung injury induced by paraquat, a prooxidant pesticide. Isolated guinea pig lungs were perfused for 60 min with Krebs-4% albumin and mechanically ventilated with 95% 02-5% CO2. Infusion of paraquat (100 mg/kg) into the pulmonary artery (n = 9 observations) increased peak airway pressure from 10.1 +/- 0.6 to 54.7 +/- 6.5 cmH2O, perfusion pressure from 8.0 +/- 0.5 to 14.9 +/- 3.0 cmH2O, wet-to-dry lung weight ratio to 7.17 +/- 0.37, and bronchoalveolar lavage protein content to 2.70 +/- 0.83 mg/ml (P < 0.01). Pretreatment with 1-3 mug.kg-1.min-1 VIP markedly attenuated or prevented all abnormalities. Of the related peptides tested, helodermin was as effective as VIP, but secretin and glucagon were ineffective. The results demonstrate that VIP and helodermin protect perfused guinea pig lungs against paraquat-induced injury and support the view that VIP has antioxidant activity.
引用
收藏
页码:L369 / L373
页数:5
相关论文
共 50 条
  • [31] VASCULAR EFFECTS OF HELODERMIN, HELOSPECTIN-I AND HELOSPECTIN-II - A COMPARISON WITH VASOACTIVE-INTESTINAL-PEPTIDE (VIP)
    GRUNDEMAR, L
    HOGESTATT, ED
    BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (03) : 526 - 528
  • [32] VASOACTIVE-INTESTINAL-PEPTIDE (VIP) - AN AMNESTIC NEUROPEPTIDE
    FLOOD, JF
    GARLAND, JS
    MORLEY, JE
    PEPTIDES, 1990, 11 (05) : 933 - 938
  • [33] GANGLIONEUROMA WITH VIP (VASOACTIVE-INTESTINAL-PEPTIDE) SECRETION
    NICOLABEFFA, F
    THOMMEN, L
    SIGNER, E
    HERZOG, B
    HELVETICA PAEDIATRICA ACTA, 1986, 41 (03) : 264 - 264
  • [34] DUAL MECHANISMS OF IMMUNOREGULATION BY VASOACTIVE-INTESTINAL-PEPTIDE
    GOETZL, EJ
    ADELMAN, DC
    ROBICHON, A
    LAU, MS
    HASSNER, A
    SREEDHARAN, SP
    CLINICAL RESEARCH, 1992, 40 (02): : A397 - A397
  • [35] PREJUNCTIONAL INHIBITION OF VASOACTIVE-INTESTINAL-PEPTIDE RELEASE
    GRIDER, JR
    MAKHLOUF, GM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (01): : G7 - G12
  • [36] FUNCTIONAL AND CONFORMATIONAL STUDIES OF VASOACTIVE-INTESTINAL-PEPTIDE
    XIAN, WJ
    BRAUNLIN, WH
    BIOPHYSICAL JOURNAL, 1994, 66 (02) : A64 - A64
  • [37] VASOACTIVE-INTESTINAL-PEPTIDE AS A BRONCHODILATOR IN SEVERE ASTHMA
    MORICE, AH
    SEVER, PS
    PEPTIDES, 1986, 7 : 279 - 280
  • [38] AUTOREGULATION OF NEUROBLASTOMA GROWTH BY VASOACTIVE-INTESTINAL-PEPTIDE
    PENCE, JC
    SHORTER, NA
    HAASE, G
    PENCE, JC
    JOURNAL OF PEDIATRIC SURGERY, 1992, 27 (08) : 935 - 944
  • [39] VASOACTIVE-INTESTINAL-PEPTIDE MESSENGER IN A NEUROIMMUNE AXIS
    WENGER, GD
    ODORISIO, MS
    GOETZL, EJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 594 : 104 - 119
  • [40] STIMULATION OF PROLACTIN SECRETION BY THE VASOACTIVE-INTESTINAL-PEPTIDE
    VYTISKABINSTORFER, E
    HUBER, JC
    KNOGLER, W
    MULLER, MM
    LEODOLTER, S
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1987, 47 (08) : 558 - 561